Helper-Polymer Based Five-Element Nanoparticles (FNPs) for Lung-Specific mRNA Delivery with Long-Term Stability after Lyophilization

被引:48
作者
Cao, Yan [1 ]
He, Zongxing [1 ]
Chen, Qimingxing [1 ]
He, Xiaoyan [1 ]
Su, Lili [1 ]
Yu, Wenxia [1 ]
Zhang, Mingming [2 ]
Yang, Huiying [3 ]
Huang, Xingxu [1 ]
Li, Jianfeng [1 ]
机构
[1] ShanghaiTech Univ, Gene Editing Ctr, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 201210, Peoples R China
[3] Fudan Univ, Huashan Hosp, Dept Pharm, Shanghai 200040, Peoples R China
关键词
stability; lung-specific; five-element nanoparticles; poly(beta-amino esters); lyophilization; LIPID NANOPARTICLES; TREHALOSE; EFFICACY;
D O I
10.1021/acs.nanolett.2c01784
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Lipid nanoparticles (LNPs) carrying therapeutic mRNAs hold great promise in treating lung-associated diseases like viral infections, tumors, and genetic disorders. However, because of their thermodynamically unstable nature, traditional LNPs carrying mRNAs need to be stored at low temperatures, which hinders their prevalence. Herein, an efficient lung-specific mRNA delivery platform named five-element nanoparticles (FNPs) is developed in which helper-polymer poly(beta-amino esters) (PBAEs) and DOTAP are used in combination. The new strategy endows FNPs with high stability by increasing the charge repulsion between nanoparticles and the binding force of the aliphatic chains within the nanoparticles. The structure-activity relationship (SAR) shows that PBAEs with E1 end-caps, higher degrees of polymerization, and longer alkyl side chains exhibit higher hit rates. Lyophilized FNP formulations can be stably stored at 4 degrees C for at least 6 months. Overall, a novel delivery platform with high efficiency, specificity, and stability was developed for advancing mRNA-based therapies for lung-associated diseases.
引用
收藏
页码:6580 / 6589
页数:10
相关论文
共 50 条
[31]   Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes [J].
Pardi, Norbert ;
Tuyishime, Steven ;
Muramatsu, Hiromi ;
Kariko, Katalin ;
Mui, Barbara L. ;
Tam, Ying K. ;
Madden, Thomas D. ;
Hope, Michael J. ;
Weissman, Drew .
JOURNAL OF CONTROLLED RELEASE, 2015, 217 :345-351
[32]  
Pogocki D, 2000, J PHARM SCI-US, V89, P443, DOI 10.1002/(SICI)1520-6017(200004)89:4<443::AID-JPS2>3.3.CO
[33]  
2-N
[34]   Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy [J].
Poland, Gregory A. .
VACCINE, 2021, 39 (03) :457-459
[35]   Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis [J].
Qiu, Min ;
Tang, Yan ;
Chen, Jinjin ;
Muriph, Rachel ;
Ye, Zhongfeng ;
Huang, Changfeng ;
Evans, Jason ;
Henske, Elizabeth P. ;
Xu, Qiaobing .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (08)
[36]   Efficiency of Cytosolic Delivery with Poly(β-amino ester) Nanoparticles is Dependent on the Effective pKa of the Polymer [J].
Routkevitch, Denis ;
Sudhakar, Deepti ;
Conge, Marranne ;
Varanasi, Mahita ;
Tzeng, Stephany Y. ;
Wilson, David R. ;
Green, Jordan J. .
ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (06) :3411-3421
[37]   High-throughput and high-content bioassay enables tuning of polyester nanoparticles for cellular uptake, endosomal escape, and systemic in vivo delivery of mRNA [J].
Rui, Yuan ;
Wilson, David R. ;
Tzeng, Stephany Y. ;
Yamagata, Hannah M. ;
Sudhakar, Deepti ;
Conge, Marranne ;
Berlinicke, Cynthia A. ;
Zack, Donald J. ;
Tuesca, Anthony ;
Green, Jordan J. .
SCIENCE ADVANCES, 2022, 8 (01)
[38]   mRNA-based therapeutics - developing a new class of drugs [J].
Sahin, Ugur ;
Kariko, Katalin ;
Tuereci, Oezlem .
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (10) :759-780
[39]   Lipid nanoparticles for nucleic acid delivery: Current perspectives [J].
Samaridou, Eleni ;
Heyes, James ;
Lutwyche, Peter .
ADVANCED DRUG DELIVERY REVIEWS, 2020, 154 :37-63
[40]   mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability [J].
Schoenmaker, Linde ;
Witzigmann, Dominik ;
Kulkarni, Jayesh A. ;
Verbeke, Rein ;
Kersten, Gideon ;
Jiskoot, Wim ;
Crommelin, Daan J. A. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 601